Wearable Focal Vibration Therapy on Upper Extremity Function of People With Multiple Sclerosis: A Pilot Study

Part of paid clinical trials in Gainesville, Florida.

Sponsor
University of Florida
Study ID
NCT07376772
Status
Recruiting
Apply to this trial

Conditions

  • Multiple Sclerosis (MS) - Relapsing-remitting
  • Upper Extremity Dysfunction

Eligibility Criteria

Sex
ALL
Age
18 Years - 100 Years
Healthy Volunteers
Not accepted

Interventions

  • wearable focal vibration therapy — DEVICE
    The focal vibration intervention will be delivered using a modified MyoVolt wearable vibration therapy device. Each MyoVolt vibration device will be assigned to a single participant for individual use only and will be clearly labeled with a unique study ID. Devices will be distributed during the baseline training session and returned at the end of the study. To prevent unauthorized use: * Participants will receive training on the appropriate use and safe handling of the device. * Each device will be stored by the participant in their home in a designated area, along with written instructions and contact information in case of any issues. * The device operates only via a linked smartphone app. This will restrict unauthorized users from easily accessing or operating the device. * Participants will be instructed not to allow others to use the device and to report any device malfunction, loss, or suspected misuse immediately to the research team.

Study Details

This pilot mixed-method study will evaluate the feasibility, preliminary efficacy, and user experience of a home-based wearable Focal Vibration Therapy (FVT) intervention for improving upper extremity (UEx) function in people with multiple sclerosis (MS). Fifteen adults with relapsing-remitting MS (PRMS) and self-reported UEx impairments will participate in a 4-week FVT program using MyovoltTM wearable FVT devices applied to arm muscles.

Key Dates

Start date
Mar 4, 2026
Status verified
Oct 2025
Primary completion
Jun 30, 2026
Completion
Jun 30, 2026

Study Design

Enrollment
15 participants (estimated)
Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
DEVICE_FEASIBILITY

Arms

  • Experimental: Intervention group
    Participants who will recieve the focal vibration therapy

Primary Outcome Measure

Nine-Hole Peg Test (9HPT) [ Time Frame: Baseline, week 4, week 8 ]

Central Contacts

Locations (2)

FacilityCityStateZIPSite coordinators
Norman Fixel Institute for Neurological DiseasesGainesvilleFlorida32608
Yun Chan Shin
[email protected]
352-273-8433
University of FloridaGainesvilleFlorida32610
Hongwu Wang, PhD
[email protected]
352-273-9934

Find similar trials in Gainesville, FL

By research site
Norman Fixel Institute for Neurological Diseases· Gainesville, FLUniversity of Florida· Gainesville, FL

Related Studies